Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified Health Condition 2: N00-N99- Diseases of the genitourinary system Health Condition 3: N921- Excessive and frequent menstruation with irregular cycle Health Condition 4: N920- Excessive and frequent menstruation with regular cycle Health Condition 5: N972- Female infertility of uterine origin Health Condition 6: N979- Female infertility, unspecified Health Condition 7: N926- Irregular menstruation, unspecified Health Con
Conditions
Interventions
Intervention1: diagnostic hysteroscopy: efficacy of lignocaine in distension medium in improving pain score- during office hysteroscopy
Control Intervention1: comparing pain: efficacy of lignocaine in
Sponsors
INSTITUTE,AIIMS NEW DELHI
Eligibility
Inclusion criteria
Inclusion criteria: 1.All women aged 20-55 years undergoing office hysteroscopy(AUB, Infertility, Recurrent pregnancy loss etc.) 2.willing to participate and sign informed written consent 3.participants falling in ASA I&II
Exclusion criteria
Exclusion criteria: 1.Those requiring operative intervention 2.Acute Pelvic Inflammatory Disease(PID) 3.Known cervical malignancy 4.Active bleeding 5.Marked cervical stenosis/Previous cervical surgery 6.Women with neurological disorders affecting evaluation of pain 7.women with h/o AV Block, sick sinus syndrome and underlying heart procedure 8.women allergic to lignocaine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| efficacy of lignocaine in distension medium in improving pain score during office hysteroscopyTimepoint: 5 minutes prior procedure during procedure 5 minutes after procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| efficacy of lignocaine in distension medium in improving pain score during office hysteroscopyTimepoint: 5 minutes prior procedure during procedure 5 minutes after procedure | — |
Countries
India
Contacts
Public ContactDr Kantesh M Katti
AIIMS-New Delhi
Outcome results
None listed